Document Detail


Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction.
MedLine Citation:
PMID:  19538738     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Severe sepsis, septic shock, and resulting organ failure represent the most common cause of death in intensive care medicine, with mortality ranging from 40% to 70%. It is still unclear whether necrosis or apoptosis plays the predominant role in severe sepsis. Determining the prevalent mode of cell death would be valuable, as new therapeutic agents (eg, antiapoptotic drugs such as caspase inhibitors) may improve unsatisfactory outcomes in patients with severe sepsis. Furthermore, the prognostic value of newly developed cell death serum biomarkers is of great interest. METHODS: In total, 147 patients (101 patients with severe sepsis, 28 postoperative patients after major abdominal surgery, 18 healthy volunteers) were enrolled. Baseline and clinical data were evaluated. Blood samples from patients with severe sepsis were collected at the time of sepsis diagnosis, and 48 and 120 hours later; samples from healthy volunteers were collected once, and from postoperative patients, once immediately after surgery. We measured caspase-cleaved and uncleaved cytokeratin-18 (CK-18, intermediate filament protein) as a marker of cell death, isolated CK-18 fragments as a marker of apoptosis, as well as IL-6, soluble vascular cell adhesion molecule, and soluble intercellular adhesion molecule. RESULTS: Age and sex of patients with severe sepsis and postoperative patients were comparable, whereas healthy volunteers were significantly younger. In healthy volunteers, the mode of cellular turnover was primarily apoptotic cell death. Postoperative patients showed comparable levels of apoptotic activity, but necrotic cell death was markedly increased, probably due to surgical tissue injury. In contrast, patients with severe sepsis, and especially non-survivors of the septic group showed increased levels of markers for both apoptotic and necrotic cell death. In severe septic patients with liver dysfunction, necrosis is increased relative to severe septic patients with intact hepatic function. For severe septic patients with liver dysfunction, a cut-off value for caspase-cleaved and uncleaved cytokeratin-18 could be calculated, in order to identify patients at high risk for death due to severe sepsis. CONCLUSIONS: The measurement of caspase-cleaved and uncleaved cytokeratin-18 appears to be an early predictor for survival in severe septic patients with hepatic dysfunction. Furthermore, the loss of parenchymal cells due to necrosis may be the primary mode of cell death in these patients. This may limit possible therapeutic options.
Authors:
Stefan Hofer; Thorsten Brenner; Christian Bopp; Jochen Steppan; Christoph Lichtenstern; Jürgen Weitz; Thomas Bruckner; Eike Martin; Ursula Hoffmann; Markus A Weigand
Related Documents :
12091178 - Microvascular blood flow is altered in patients with sepsis.
7743718 - Hypoxia and myocardial ischaemia during peripheral angioplasty.
2624698 - Legionnaire's pneumonia complicating a thermal burn.
10921548 - Transcutaneous oxygen and co2 as early warning of tissue hypoxia and hemodynamic shock ...
7603918 - Tricon hybrid total knee arthroplasty: a review of 81 knees followed for 2 to 4 years.
12599088 - Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infec...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-06-18
Journal Detail:
Title:  Critical care (London, England)     Volume:  13     ISSN:  1466-609X     ISO Abbreviation:  Crit Care     Publication Date:  2009  
Date Detail:
Created Date:  2009-07-29     Completed Date:  2009-10-28     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  9801902     Medline TA:  Crit Care     Country:  England    
Other Details:
Languages:  eng     Pagination:  R93     Citation Subset:  IM    
Affiliation:
Department of Anaesthesiology, University of Heidelberg, Im Neuenheimer Feld 110, D-69120 Heidelberg, Germany. Stefan.Hofer@med.uni-heidelberg.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Biological Markers / blood
Case-Control Studies
Cell Death*
Female
Germany / epidemiology
Humans
Intercellular Adhesion Molecule-1 / blood
Interleukin-6 / blood
Keratin-18 / blood*
Liver Failure, Acute / blood*,  mortality
Logistic Models
Male
Middle Aged
Multiple Organ Failure / blood,  mortality
Prognosis
Sepsis / blood*,  mortality
Survival Analysis
Vascular Cell Adhesion Molecule-1 / blood
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Interleukin-6; 0/Keratin-18; 0/Vascular Cell Adhesion Molecule-1; 126547-89-5/Intercellular Adhesion Molecule-1
Comments/Corrections
Comment In:
Crit Care. 2009;13(4):173   [PMID:  19678906 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  PAR1 is selectively over expressed in high grade breast cancer patients: a cohort study.
Next Document:  Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells.